Basket | Login | Register

 
 
 
 

GENERATION S2 study (coming soon)

Clinical Trials Watch

Scientific title

A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease 

Study sponsor

Novartis

Disease

People at higher risk of developing Alzheimer’s dementia

Name of drug

CNP520

Link to full text

https://www.clinicaltrials.gov/ct2/show/study/NCT03131453?term=cnp520&recrs=ab&rank=1&show_locs=Y#locn

Please note that an accessible easy read version of this study is not yet available. The pharmaceutical company running this trial and a member of the European Working Group of People with Dementia are currently reviewing this document.

 

 
 

Last Updated: Friday 10 November 2017

 

 
 

Options